Netflix Documentary “The Remarkable Life of Ibelin” Honored at 2026 EURORDIS Black Pearl Awards

Netflix Documentary “The Remarkable Life of Ibelin” Honored at 2026 EURORDIS Black Pearl Awards

Brussels — On February 24, 2026, the acclaimed Netflix documentary The Remarkable Life of Ibelin received the Media & Awareness Raising Award at the EURORDIS Black Pearl Awards. The honor recognizes the film’s extraordinary role in elevating global awareness for the 300 million people living with rare diseases—specifically Duchenne muscular dystrophy (DMD).

A Story of Boundless Connection

The film follows the life of Mats Steen, a young Norwegian with Duchenne who passed away at age 25. While his parents  Trude and Robert  Steen initially grieved what they feared was an isolated existence, they discovered after his death that Mats had lived a vibrant life, forming deep, global bonds through the World of Warcraft gaming community. The life that Mat experienced inside Azeroth  allowed him to experience things virtually that his muscular dystrophy did not allow actually and this was  meaningful and important. The film blends scenes from his home life, and the outpouring of grief and empathy from his life in the “world” and from his blog  which poignantly shares his love and connection with family while contemplating what he knew would be a short life.

“Through The Remarkable Life of Ibelin, Mat’s legacy extends far beyond his own life,” said Debra Miller, Founder and CEO of CureDuchenne. “It gives voice to not just those with Duchenne, but to the more than 300 million people around the world living with a rare disease.”

Turning Awareness into a $2 Million Impact

Mats’ story has moved viewers to tears and inspired historic action. Working with Blizzard Entertainment, a World of Warcraft charity campaign inspired by the film raised over $2 million for CureDuchenne. These funds are driving innovative, early-stage research aimed at finding a cure.

To date, CureDuchenne has:

  • Invested more than $27 million in life-saving research.
  • Funded the first FDA-approved treatment for Duchenne.
  • Helped bring 18 programs into human clinical trials.
  • Catalyzed more than $3 billion in follow-on investment from the biotech and pharma sectors.

A Tool for Meaningful Change

Since its 2024 Sundance premiere—where it won both the Audience and Directing awards—the film has earned 14 awards and 31 nominations.

“This film is a powerful reminder that storytelling can be one of the most effective tools we have to drive awareness, foster understanding, and inspire meaningful change,” said Virginie Hivert, Acting CEO of EURORDIS-Rare Diseases Europe.

The Remarkable Life of Ibelin is currently streaming on Netflix.